Related Experiment Video
Updated: Mar 6, 2026
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
"Gotta Catch 'em All", or Do We? Pokemet Approach to Metastatic Prostate Cancer
Declan G Murphy1, Christopher J Sweeney2, Bertrand Tombal3
1Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Australian Prostate Cancer Research Centre, Epworth Healthcare, Richmond, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
Abstract:
Metastasis-directed therapy is of interest for the management of oligometastatic prostate cancer. Improved imaging may help with patient selection, but the approach to metastatic prostate cancer of "catching 'em all", or "Pokemet", must be considered experimental.
Insights
Metastasis-directed therapy shows promise for oligometastatic prostate cancer. Advanced imaging aids patient selection, but the "Pokemet" approach for widespread metastatic prostate cancer remains experimental.
Area of Science:
- Oncology
- Medical Imaging
Background:
- Metastasis-directed therapy (MDT) is being explored for oligometastatic prostate cancer.
- Improved imaging techniques are crucial for identifying suitable candidates for MDT.
Discussion:
- The "Pokemet" strategy, aiming to target all metastatic sites, is a novel concept in prostate cancer management.
- This comprehensive approach requires careful consideration due to its experimental nature.
Key Insights:
- Patient selection is paramount for the success of metastasis-directed therapy in prostate cancer.
- Current imaging advancements may enhance the identification of patients with limited metastatic burden.
Outlook:
- Further research is needed to validate the efficacy and safety of the "Pokemet" approach.
- The role of MDT in the evolving landscape of prostate cancer treatment warrants continued investigation.
